Adipose tissue is a critical endocrine and immunological organ that regulates systemic energy homeostasis. During the pathogenesis of obesity, adipocyte hypertrophy is accompanied by adipose tissue inflammation, impeding insulin sensitivity and endocrine function of adipose tissue and other tissues. Adipocyte cholesterol accumulates in proportion to triglyceride as adipocytes undergo hypertrophy. Recent studies suggest that dietary cholesterol contributes to increased adipocyte cholesterol. However, how dietary cholesterol accumulates in adipocytes and its metabolic consequences are poorly understood. This review summarizes recent advances in knowledge of adipocyte cholesterol balance and highlights the emerging role of dietary cholesterol in adipose tissue cholesterol balance, inflammation, and systemic energy metabolism.
INTRODUCTION
Adipose tissue is a versatile and active endocrine organ [1 & ]. Adipocytes secrete hormones (adipokines) [2] , store excess energy as triglyceride , release fatty acids (FA) during fasting, contribute to systemic glucose disposal [3] , and participate in HDL biogenesis [4] . During the progression of obesity, in which chronic energy intake exceeds expenditure, adipose tissue undergoes significant cellular changes, so-called 'adipose tissue remodeling', triggering hypertrophic adipocyte expansion and adipose tissue immune cell infiltration [5] [6] [7] . Enlarged adipocytes exhibit decreased insulin responsiveness, decreased glucose uptake, and increased secretion of proinflammatory adipokines [8] [9] [10] [11] . Cholesterol accumulation and redistribution from the plasma membrane to the lipid droplet monolayer is a crucial determinant of adipocyte function during hypertrophic expansion [12] [13] [14] [15] [16] [17] [18] .
Rodent models of diet-induced obesity using a high fat diet are well established to promote adipocyte hypertrophy and adipose tissue macrophage infiltration [19, 20] ; however, little is known regarding the role of dietary cholesterol in these processes. New studies, summarized below, now suggest an important role for dietary cholesterol as an independent inducer of adipocyte hypertrophy and adipose tissue inflammation.
This review consists of three parts in which we summarize the current knowledge concerning: cholesterol as a determinant of adipocyte size and function, regulators of adipocyte cholesterol balance, and effects of dietary cholesterol on adipose tissue inflammation.
Cholesterol as a determinant of adipocyte size and function
Adipose tissue is a major site for free cholesterol storage in humans. About 25% of the body pool of cholesterol is stored in adipose depots, which can increase to 50% in obese states [21] . As adipocyte hypertrophy progresses during obesity development, cellular cholesterol content increases [12] . A distinguishing feature of adipocyte cholesterol compared with other cholesterol-laden cell types is the relative lack of esterified cholesterol; >95% of adipose cholesterol is free cholesterol [14] . Owing to its polar carbon 3 hydroxyl group in the steroid backbone, free cholesterol has limited solubility (2-3%) in the core of lipid droplets [22] . However, free cholesterol does accumulate in the lipid droplet phospholipid monolayer interface and in the plasma membrane [23] . During hypertrophic expansion, adipocytes acquire more free cholesterol and redistribute free cholesterol from the plasma membrane to the lipid droplet interface, resulting in a relative deletion of plasma membrane free cholesterol and enrichment of lipid droplet monolayer free cholesterol [12] [13] [14] [15] [16] [17] [18] . For example, the plasma membrane free cholesterol/protein ratio decreases 40-50% in larger (50 mm diameter) versus small (40 mm diameter) adipocytes isolated from lean rats [15] and in subcutaneous adipocytes isolated from obese versus lean rats [16] . Differentiation of 3T3-L1 preadipocytes into triglyceride-enriched adipocytes is associated with decreased plasma membrane free cholesterol [24] .
Adipocyte free cholesterol content affects adipocyte function. For example, methyl-b-cyclodextrin-mediated cholesterol depletion of 3T3-L1 adipocytes results in defective glucose uptake and oxidation, diminished GLUT-4 expression, and impaired insulin signaling [15, 25] . Decreasing 3T3-L1 adipocyte free cholesterol content by incubation with methyl-b-cyclodextrin, apolipoprotein A-I (apoA-I), or HDL decreased plasma membrane lipid rafts, leading to decreased palmitate-induced inflammation, reactive oxygen species, and monocyte chemotactic factor expression [26] . In vivo, transgenic overexpression of apoA-I in mice fed with a diet high in fat, sucrose, and cholesterol led to decreased adipose tissue inflammation and macrophage content compared with nontransgenic controls, presumably by reducing adipocyte free cholesterol content [26] . These combined results suggest that optimal adipocyte membrane free cholesterol is necessary to preserve normal adipocyte function.
Regulators of adipocyte cholesterol balance
Adipocytes acquire cholesterol through de novo biosynthesis and lipoprotein uptake, and eliminate excess free cholesterol by protein-mediated efflux. De novo cholesterol biosynthesis is reportedly very low in adipocytes [12, 13] and uptake of plasma LDL by the LDL receptor is also low relative to the liver [27] . Adipocytes also bind lipoproteins via the scavenger receptor class B, member 1 (SR-BI), LDL receptor-related protein 1, and the VLDL receptor, providing additional pathways for cholesterol uptake from circulating plasma lipoproteins [28] [29] [30] [31] .
A direct correlation between dietary cholesterol levels and adipocyte cholesterol content was first identifed in a rat model [13] . In general, dietary cholesterol levels appear more strongly correlated with adipocyte cholesterol content than plasma cholesterol concentrations [13, 21] . This
KEY POINTS
During progression of obesity, adipocyte size increases with the accumulation of triglyceride and free cholesterol, and adipose tissue inflammation and adipocyte dysfunction ensues.
Although excess caloric consumption partially mediates obesity, the role of individual dietary constituents, particularly cholesterol, in development of obesity is poorly understood.
Emerging evidence supports a critical role for adipocyte free cholesterol in controlling adipocyte size and function, and several key proteins (VLDLR, ABCA1, ABCG1, PLTP, and SR-BI) have recently been identified as important in maintaining adipocyte free cholesterol homeostasis.
Recent studies demonstrate that high dietary cholesterol consumption leads to increased adipose tissue inflammation and dysfunction in mice and nonhuman primates, and that inhibition of cholesterol absorption with ezetimibe results in reduced plasma biomarkers of adipose tissue inflammation in hypercholesterolemic patients. These combined results suggest that reducing high dietary cholesterol intake may be an efficient way to reduce adipose tissue inflammation and dysfunction.
relationship likely results from adipocyte uptake of chylomicron, chylomicron remnant, and VLDL particles that contain dietary cholesterol cargo and apolipoprotein E (apoE), a ligand for the VLDL receptor (VLDLR) and LRP receptors [29] [30] [31] [32] [33] . ApoE appears important in adipocyte triglyceride accumulation, since adipose tissue from apoE knockout mice has less triglyceride compared with wild-type mice [34,35 & ]. Insulin stimulates the activity of LRP on primary adipocytes, resulting in increased uptake of cholesteryl esters from apoEenriched b-VLDL [32] . The VLDLR binds to apoEcontaining triglyceride-rich lipoproteins, enhancing lipoprotein lipase (LPL) activity and cellular lipid entry [36] . Although not expressed in adipocyte precursor cells, VLDLR expression is upregulated in differentiated adipocytes [37] , allowing the simultaneous acquisition of dietary cholesterol and triglyceride from lipoproteins. Mice lacking the VLDLR were leaner and resistant to the high fat diet-mediated weight gain because of reduced LPL activity and attenuated FA uptake [38] . Nguyen et al. [39 && ] reported that VLDLR deficiency also significantly attenuated adipocyte inflammation mediated by a high-fat diet, confirming that VLDLR expression is crucial in regulating adipocyte size and function. Intriguingly, deletion of proprotein convertase subtilisin/kexin 9, which normally promotes liver LDLR degradation, increased triglyceride accumulation in visceral fat by enhancing expression of VLDLR in adipocytes [40] . Taken together, these studies suggest that circulating triglyceriderich lipoproteins are the primary source of adipocyte cholesterol and that cholesterol uptake occurs in association with triglyceride accrual through membrane-anchored lipoprotein receptors, such as VLDLR and LPR.
Excess adipocyte free cholesterol is effluxed to apoA-I and other amphipathic apolipoproteins via the ATP-binding cassette transporter A1 (ABCA1), forming nascent HDL particles, or to plasma HDL particles by SR-BI and ATP-binding cassette transporter G1 (ABCG1) [41] . Zhang et al. [42] first showed that adipocyte cholesterol transporters were important for adipocyte cholesterol efflux. Using differentiated mouse embryonic fibroblasts from ABCA1 -/-, SR-B1 -/-, and ABCG1 -/mice, they identified ABCA1 and SR-BI, but not ABCG1, as major cholesterol transporters for effluxing free cholesterol from adipocytes to apoAI and HDL, repectively [42] .
A critical in-vivo role for ABCA1 in adipocyte cholesterol efflux and cellular cholesterol homeostasis was elucidated using ABCA1 flox/flox mice crossed with 'aP2 Cre' recombinase mice to generate adipocyte-specific ABCA1 knockout (ASKO) mice [4] . ASKO mice generated by this strategy had almost no ABCA1 protein expression in adipocytes, but partial and variable macrophage expression. ASKO mice had a striking increase in adipocyte cholesterol content and a small (15%), but significant, decrease in plasma HDL cholesterol concentrations, suggesting that adipocyte ABCA1 provides a finite source of the plasma HDL cholesterol pool [4] . In another study, high fat-high cholesterol (HFHC)fed ASKO mice demonstrated increased body weight, larger fat pad mass, increased adipose tissue cholesterol content, and impaired glucose tolerance and insulin sensitivity compared with control mice [43 & ]. However, interpretation of the systemic metabolic results from the latter study is confounded by the partial and variable ABCA1 expression in macrophages, which are the main source of adipose tissue proinflammatory cytokine production that reduces insulin sensitivity [44] . Future studies using adipocyte-specific ABCA1 deletion with intact macrophage ABCA1 expression will be necessary to clarify the role of ABCA1 in adipocyte function.
Although in-vitro studies suggest ABCG1 does not play a significant role in adipocyte cholesterol efflux [42] , an in-vivo study showed that whole body ABCG1 knockout mice consuming a high-fat diet weighed less than their wild-type counterparts and had smaller fat pads and reduced adipocyte size, presumably because of increased energy expenditure and body temperature and decreased food intake [45] . The high fat-fed ABCG1 knockout mice had minimal changes in systemic metabolism, including decreased nonesterified FA after a 24-h fast and improved plasma glucose clearance. A recent study showed that ABCG1 silencing in 3T3-L1 adipocytes resulted in decreased triglyceride accumulation, smaller lipid droplet size, and decreased activity of LPL, an enzyme that hydrolyzes triglycerides to FA for uptake by cells [46 && ]. Paradoxically, although free cholesterol efflux from 3T3 cells was compromised with ABCG1 silencing, cellular free cholesterol was actually decreased to 33% of that in control cells [46 && ]. Local silencing of ABCG1 in epididymal white adipose tissue (eWAT) of HFHC-fed mice using lentiviruses expressing short hairpin RNAs resulted in decreased body weight, and smaller eWAT pads and adipocytes, with no change in food intake or physical activity relative to mice injected with control lentivirus [46 && ]. The authors suggest that defective sphingomyelin efflux in the absence of ABCG1 expression results in increased plasma membrane sphingomyelin and lipid raft content, which in turn, inhibits LPL activity, limiting uptake of FA and triglyceride accretion by adipocytes.
Supporting the in-vitro and mouse studies are results demonstrating an ABCG1 haplotype that is associated with increased adiposity in humans [46 && ]. However, as with ABCA1 studies summarized above, results of studies using whole body ABCG1 knockout mice or eWAT silencing of ABCG1 should be interpreted with caution, as macrophage ABCG1 expression was also diminished in both studies. Clarification of the role of adipocyte ABCG1 in obesity and metabolism must await studies using adipocyte-specific ABCG1 knockout mice.
Another recent study using knockout mice and bone marrow transplantation experiments demonstrated that adipocyte phospholipid transfer protein stimulates adipocyte free cholesterol efflux and contributes a small, but significant, pool of plasma HDL cholesterol [47 & ]. These studies suggest that adipocyte phospholipid efflux increases adipocyte free cholesterol efflux and may contribute to the overall regulation of adipocyte free cholesterol : triglyceride ratio.
Although adipocyte expression of ABCA1 and ABCG1 and free cholesterol efflux are proportional to adipocyte size and triglyceride content, the reason for this association is not clear. A recent study suggests that cholesterol efflux from adipocytes to apoA-I and HDL, presumably via ABCA1 and ABCG1, respectively, activates hormone-sensitive lipase-induced lipolysis of adipocyte triglyceride, simultaneously decreasing adipocyte free cholesterol and triglyceride [48 && ]. This process likely maintains a similar free cholesterol : triglyceride ratio as adipocytes become smaller, and may be a compensatory mechanism to maintain optimal adipocyte function as adipocyte size decreases or increases during triglyceride lipolysis or accretion.
Additional questions remain regarding adipocyte free cholesterol content and adipocyte cell death [49] , other dietary constituents (e.g., phospholipids, n-3 polyunsaturated FA [50 & ,51 && ], or vitamin D [52] ) that may influence adipose tissue cholesterol balance, and unidentified membranebound or intracellular regulators controlling adipocyte cholesterol balance.
Effects of dietary cholesterol on adipose tissue inflammation
The general rule that large adipocytes are more inflamed than smaller ones is well established by numerous studies showing that overnutrition instigates AT remodeling [5] . Although dietary cholesterol may be a primary source of AT cholesterol, the relationship between dietary cholesterol and adipose inflammation is not fully understood. For example, inhibition of intestinal cholesterol absorption with ezetimibe in mice did not affect AT inflammation or adipocyte size, despite less weight gain and reduced plasma serum amyloid protein concentrations compared with control mice [53] . However, another study observed improved insulin sensitivity in ezetimibe-treated mice fed a HFHC diet [54] . A confounding feature of these studies is a decrease in absorption of saturated FA, which may independently affect adipose tissue and insulin resistance outcomes [53, 54] .
A recent study in patients with hypercholesterolemia demonstrated that combination ezetimibesimvastatin treatment decreased plasma leptin, visfatin, tumor necrosis factor a, and FA concentrations, and increased adiponectin levels compared with patients treated with simvastatin alone [55 & ]. Furthermore, the effect of the combined therapy on markers of systemic inflammation was stronger in insulin-resistant than in insulin-sensitive individuals. These results are compatible with the hypothesis that blocking cholesterol absorption reduces adipose tissue inflammation.
A seminal study by Subramanian et al. [19] demonstrated that mice fed dietary cholesterol (0.15% w/w) had increased high fat diet-induced weight gain, adipocyte size, macrophage infiltration, and proinflammatory cytokine expression compared with mice fed with an isocaloric high fat diet without added cholesterol, establishing a positive association between dietary cholesterol and adipose tissue inflammation. Dietary cholesterol was also associated with attenuated insulin sensitivity and increased atherosclerosis [19] .
However, rodents and humans have distinct differences in cholesterol metabolism [27] . To overcome this limitation, Chung et al. [56 && ] designed a study to determine the role of dietary cholesterol in adipocyte hypertrophy and inflammation in nonhuman primates (African green monkeys), which are phylogenetically more similar to humans than rodents. Monkeys were fed one of three isocaloric diets containing 0.002, 0.2, or 0.4 mg cholesterol/ kcal for 10 weeks. Increasing dietary cholesterol resulted in increased adipocyte size and adipose tissue free cholesterol accumulation, macrophage content, and proinflammatory gene expression in visceral, but not subcutaneous, fat. In visceral fat, increased dietary cholesterol intake was also associated with decreased expression of genes involved in cholesterol biosynthesis and lipoprotein uptake and increased expression of proteins involved in cholesterol efflux. Interestingly, these changes occurred without significant changes in body weight among diet groups, differing from results in HFHC diet-fed mice [19] . Why visceral fat had a different response to increased dietary cholesterol versus subcutaneous fat is unknown and will require further investigation.
Although the metabolic consequences of highcholesterol diets in mice and nonhuman primates were not identical, the fundamental concept that dietary cholesterol promotes proinflammatory remodeling of adipose tissue (i.e., adipocyte hypertrophy and macrophage infiltration) was firmly established by these studies.
Another intriguing question is whether dietary cholesterol affects WAT browning, characterized by the emergence of brown-like adipocytes (beige) CM triglyceride is hydrolyzed to free fatty acids by lipoprotein lipase, resulting in CM remnant particles, FA uptake, and re-esterification into triglyceride that is stored in the adipocyte lipid droplet. CMR, which are enriched with dietary cholesterol, bind to VLDL receptors expressed on the adipocyte plasma membrane through apolipoprotein E and are internalized, leading to a simultaneous increase in triglyceride and free cholesterol content as adipocytes hypertrophy. During adipocyte hypertrophy, free cholesterol redistributes from the plasma membrane to the lipid droplet monolayer, resulting in a relative depletion of plasma membrane free cholesterol, which leads to adipocyte dysfunction, increased adipose tissue inflammation, and decreased insulin sensitivity. Optimal plasma membrane sphingomyelin content, maintained by ABCG1, appears necessary to maintain lipoprotein lipase activity for CM triglyceride hydrolysis and adipocyte FA uptake. (b) When adipocyte size decreases during lipid droplet triglyceride hydrolysis to FA, adipocyte free cholesterol content is decreased via free cholesterol efflux to apoA-I, mediated by ABCA1, and to HDL, mediated by SRBI and probably by ABCG1, helping maintain a relativity constant free cholesterol : triglyceride ratio for optimal adipocyte function. Thus, as adipocyte size and triglyceride content is reduced, free cholesterol from the lipid droplet redistributes to the plasma membrane, restoring insulin sensitivity and reducing adipose tissue inflammation. Adipocyte phospholipid transfer protein activity may also be necessary for optimal free cholesterol efflux and nascent HDL particle formation. ABCA1, ATP binding cassette transporter A1; CM, chylomicron; CMR, chylomicron remnants; FA, free fatty acid LPL, lipoprotein lipase; mf, macrophage; nHDL, nascent HDL; PLTP, phospholipid transfer protein; SM, sphingomyelin; SRBI, scavenger receptor class B, member 1; TG, triglyceride; VLDLR, VLDL receptor. within WAT that dissipate energy via mitochondrial uncoupling of oxidative phosphorylation and ATP production. Currently, no studies have tested the role of dietary cholesterol on WAT browning. However, recent studies have shown that M2 macrophage polarization promotes WAT browning [57, 58] , whereas obesity-mediated Toll-like receptor 4 activation of M1 macrophages abrogates WAT browning [59] . Given recent evidence that high dietary cholesterol intake promotes proinflammatory WAT remodeling, it is likely that dietary cholesterol intake is negatively associated with WAT browning, although this idea has not been formally tested.
CONCLUSION
Free cholesterol is a metabolically dead-end molecule -it cannot be degraded by cells and is toxic at high concentrations. Hence, most cells restrict free cholesterol accumulation and toxicity by esterifying free cholesterol to inert cholesteryl esters. However, unlike other cells, adipocytes can accumulate high levels of free cholesterol as cell size increases with triglyceride storage. Adipocyte free cholesterol content, a critical determinant of adipocyte size and function, is maintained by a balance between dietary cholesterol uptake through circulating lipoproteins and free cholesterol efflux to apolipoproteins and HDL. Recent data support the concept that increased dietary cholesterol promotes adipose tissue remodeling and inflammation (Fig. 1 ). Whether these initial findings in rodents and nonhuman primates will be confirmed in humans must await future studies. Based on available data in animal models, AT cholesterol content appears to be a novel and viable target to attenuate AT inflammation and attendant metabolic complications. A recent human study supports the notion that inhibiting intestinal absorption may attenuate AT inflammation in the absence of body weight loss [55 & ]. Thus, recommending a prudent intake of dietary cholesterol potentially could be a simple strategy to lessen adipocyte hypertrophy and dysfunction, even without weight loss.
